Overview New York, NY – Oct 27, 2025 – The Global Cardiac Resynchronization Therapy Market size is expected…
Continue ReadingTag: Therapy
Rethinking Heart Failure Therapy in the Fontan Circulation
For decades, the Fontan operation has stood as one of the great surgical triumphs in congenital…
Continue Reading
Too Few HF Patients on Guideline-Directed Medical Therapy in VA System
Costs aren’t the only barrier to achieving optimal medication adherence, the data indicate. MINNEAPOLIS, MN—Fewer than…
Continue Reading
BioCardia CEO to Present CardiAMP Heart Failure Cell Therapy Updates at AGP Healthcare Event
BioCardia (NASDAQ:BCDA), a developer of cellular and cell-derived…
Continue Reading
Press release: First-in-human drug therapy trial for heart failure patients performed at The Christ Hospital Health Network
CINCINNATI (March 18, 2025) – The Christ Hospital Health Network became the first site internationally to…
Continue Reading
Rochester Regional Health’s Sands-Constellation Heart Institute Becomes First U.S. Site for Groundbreaking Heart Failure Therapy Clinical Trial
ROCHESTER, NY – Rochester General Hospital (RGH) is the first U.S. site of a groundbreaking pivotal…
Continue Reading